In these pts who are not in 1 of the 4 statin benefit groups, discuss potential for risk-reduction benefits, adverse effects, drug interactions, pt preferences, etc, to inform tx decisions. Consider these additional factors: [E]

By vgreene, 19 May, 2015
Exclude Patient Type Detail Header
No
Detail Type
Text
Detail Text
Primary LDL-C ≥160 mg/dL, or other evidence of genetic hyperlipidemia
Family hx premature AS-CVD w/ onset
High-sensitivity CRP ≥2 mg/L
Coronary artery calcium score ≥300 Agatston units or ≥75th percentile for age/sex/ethnicity
ABI <0.9
Elevated lifetime risk of AS-CVD
Patient Type Detail Header (Long)
In these pts who are not in 1 of the 4 statin benefit groups, discuss potential for risk-reduction benefits, adverse effects, drug interactions, pt preferences, etc, to inform tx decisions. Consider these additional factors: [E]